Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 11/16/2025 By Casper MillerNovember 19, 2025
Leveraged & Inverse Content Hub New FDA Director Could Sway Biotech ETFs By Ben HernandezNovember 14, 2025
Leveraged & Inverse Content Hub As M&A Deals Rise, Can Biotech Pharma Break Loose? By Ben HernandezSeptember 19, 2025
Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 09/07/2025 By Sneha ShahSeptember 9, 2025
Leveraged & Inverse Content Hub Market Mania: May the Earnings Beat Be With You By DirexionAugust 27, 2025
Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 08/17/2025 By Sneha ShahAugust 19, 2025
Leveraged & Inverse Content Hub Rising Number of Flu Cases Could Elevate These ETFs By Ben HernandezFebruary 24, 2025
Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 01/26/2025 By Sneha ShahJanuary 30, 2025
Leveraged & Inverse Content Hub Trading Q4 Earnings: Will Bulls Fly or Just Get Gored? By DirexionJanuary 30, 2025
Leveraged & Inverse Content Hub There Could Be Value in Healthcare Stocks Ahead of 2025 By Ben HernandezDecember 13, 2024
Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 12/01/2024 By Sneha ShahDecember 4, 2024
Leveraged & Inverse Content Hub Q3 Earnings Season: Outlook Looks Murky for Traders By DirexionNovember 25, 2024
Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 07/28/2024 By Sneha ShahJuly 30, 2024
Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 07/14/2024 By Sneha ShahJuly 16, 2024
Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 05/05/2024 By Sneha ShahMay 7, 2024
Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 03/03/2024 By Sneha ShahMarch 5, 2024
